Publicacións nas que colabora con Nieves Purificacion Martinez Lago (9)
2025
-
Efficacy and safety of trifluridine/tipiracil and bevacizumab (FTD/TPI+BEV) in patients with metastatic colorectal cancer (mCRC) in real-world practice.
Journal of Clinical Oncology, Vol. 43, Núm. 4_suppl, pp. 204-204
-
Immune checkpoint inhibitors in digestive tumors with mismatch repair deficiency or microsatellite instability (dMMR/MSI-H): Effectiveness, safety, and prognostic factors in real-world practice.
Journal of Clinical Oncology, Vol. 43, Núm. 4_suppl, pp. 202-202
2024
-
517P Real-world efficacy and safety of immune checkpoint inhibitors (ICI) in gastrointestinal tumors with mismatch repair deficiency or microsatellite instability (dMMR/MSI-H)
Annals of Oncology, Vol. 35, pp. S206
-
Real-world effectiveness and safety of pembrolizumab in mismatch repair-deficient (dMMR) gastrointestinal non-colorectal tumors.
Journal of Clinical Oncology, Vol. 42, Núm. 3_suppl, pp. 733-733
-
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD Group
Targeted Oncology, Vol. 19, Núm. 4, pp. 565-573
2021
-
Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method
Healthcare (Switzerland), Vol. 9, Núm. 6
2020
-
Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359
2019
-
Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen
Annals of Oncology, Vol. 30, pp. iv42-iv43
-
Is there any affordable and reliable score in local gastric cancer?
Annals of Oncology, Vol. 30, pp. iv60